Results 331 to 340 of about 205,027 (361)
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Age-related macular degeneration
The Lancet, 2023Age-related macular degeneration is an increasingly important public health issue due to ageing populations and increased longevity. Age-related macular degeneration affects individuals older than 55 years and threatens high-acuity central vision required for important tasks such as reading, driving, and recognising faces.
R. Guymer, Thomas Gordon Campbell
semanticscholar +3 more sources
Age-Related Macular Degeneration
The Lancet, 2012Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in the developed world. Despite recent advances in treatment, AMD causes considerable morbidity. For the non-ophthalmologist, a brief background on retinal structure is provided, followed by a description of the characteristic changes seen in AMD.
Khandhadia, Sam +2 more
openaire +5 more sources
Age-related macular degeneration
British Journal of Hospital Medicine, 2005Age-related macular degeneration is the leading cause of irreversible loss of vision in the west, accounting for up to 50% of all blind registrations. With an ageing population age-related macular degeneration will have a discernible impact on society and the NHS.
Ahmed N, El-Amir +2 more
openaire +2 more sources
Age-related macular degeneration
Insight - the Journal of the American Society of Ophthalmic Registered Nurses, 1997Age-related macular degeneration (AMD) is one of the leading causes of legal blindness among older adults. Early recognition of AMD is important because treatment can enable patients to maintain central vision longer. Nurses who understand the effects of AMD can teach their elderly patients ways to slow its progression, such as increasing consumption ...
openaire +3 more sources
Age-related macular degeneration
The Lancet, 2018Age-related macular degeneration is a leading cause of visual impairment and severe vision loss. Clinically, it is classified as early-stage (medium-sized drusen and retinal pigmentary changes) to late-stage (neovascular and atrophic). Age-related macular degeneration is a multifactorial disorder, with dysregulation in the complement, lipid, angiogenic,
P. Mitchell +3 more
semanticscholar +3 more sources
Age-Related Macular Degeneration
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly, and the prevalence of the disease increases exponentially with every decade after age 50 years. It is a multifactorial disease involving a complex interplay of genetic, environmental, metabolic, and functional factors.
Lily K, Cheung, Angie, Eaton
openaire +2 more sources
What Is Age-Related Macular Degeneration?
Journal of the American Medical Association (JAMA)This JAMA Patient Page describes age-related macular degeneration development and progression; symptoms and risk factors; and diagnosis, monitoring, and treatment.
Rebecca A Voelker
semanticscholar +1 more source
Age‐related macular degeneration in Inuit
Acta Ophthalmologica Scandinavica, 1999To describe a specific Greenlandic type af age-related macular degeneration (AMD) - the Retinochoroidal Atrophy (RCA).135 referred patients in East Greenland were examined in 1997. A colour and a redfree fundus photograph of an 87-year-old Greenlandic woman illustrates the clinical picture of RCA (retinochoriodal atrophy).Of 135 examined patients 22 ...
openaire +4 more sources